Insider · CIK 0001415780

Celeste Anthony C.

Reports to the SEC for 1 company · BETHESDA, MD

sec.gov

Transactions

Companies

Filings

CIK

0001415780

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-03-11	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,800 sh	$4.41	+$21.2K	4,800
2015-03-11	Sucampo Pharmaceuticals, Inc.S Sale	Director	SSale	−4,800 sh	$17.34	−$83.2K	0
2015-03-11	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,500 sh	$4.41	+$19.8K	4,500
2015-03-11	Sucampo Pharmaceuticals, Inc.S Sale	Director	SSale	−4,500 sh	$17.34	−$78K	0
2015-03-11	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$7.71	+$154K	20,000
2015-03-11	Sucampo Pharmaceuticals, Inc.S Sale	Director	SSale	−20K sh	$17.34	−$347K	0
2015-03-11	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$8.62	+$172K	20,000
2015-03-11	Sucampo Pharmaceuticals, Inc.S Sale	Director	SSale	−20K sh	$17.34	−$347K	0
2015-03-11	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.7K sh	$6.80	+$113K	16,666
2015-03-11	Sucampo Pharmaceuticals, Inc.S Sale	Director	SSale	−16.7K sh	$17.34	−$289K	0
2015-03-11	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,800 sh	—	—	71,400
2015-03-11	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,500 sh	—	—	66,900
2015-03-11	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	46,900
2015-03-11	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	26,900
2015-03-11	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−16.7K sh	—	—	10,234
2014-02-14	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$5.10	+$153K	35,000
2014-02-14	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$3.56	+$71.2K	55,000
2014-02-14	Sucampo Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+13.8K sh	$4.41	+$60.9K	68,800
2014-02-14	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	90,000
2014-02-14	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	70,000
2014-02-14	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	—	—	61,000
2014-02-14	Sucampo Pharmaceuticals, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,800 sh	—	—	56,200
2013-05-22	Sucampo Pharmaceuticals, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	120,000
2012-05-25	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-05-02	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2011-05-02	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2010-05-20	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2009-10-07	Sucampo Pharmaceuticals, Inc.Employee Stock Option (Right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2009-09-03	Sucampo Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+1,100 sh	$5.00	+$5,500	5,000
2009-09-02	Sucampo Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+2,500 sh	$5.03	+$12.6K	3,900
2009-09-02	Sucampo Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+1,400 sh	$5.00	+$7,000	1,400

Recent filings

Accepted (ET)
Mar 184
Sucampo Pharmaceuticals, Inc.0001171843-15-001493
SEC(opens sec.gov)
Feb 194
Sucampo Pharmaceuticals, Inc.0001171843-14-000807
SEC(opens sec.gov)

Companies

Sucampo Pharmaceuticals, Inc.Director

Address

4520 EAST WEST HWY SUITE 300

BETHESDA, MD, 20814